HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravitreal triamcinolone acetonide injection for acute non-arteritic anterior ischaemic optic neuropathy.

Abstract
Non-arteritic anterior ischaemic optic neuropathy is the most common optic neuropathy of the elderly, characterised by unilateral, sudden, painless visual loss. No effective treatment has been proven to reverse or limit the course of this disease. We evaluated the role of intravitreal triamcinolone acetonide injection in eyes with non-arteritic anterior ischaemic optic neuropathy (NAION). Four eyes of four patients with acute NAION received a single intravitreal injection of triamcinolone acetonide (4 mg). The time between visual loss and intravitreal injection varied between four and 10 days. Mean age of patients was 57.25 years (range, 44 to 77 years). All patients experienced some visual gain. No complications related to the injection were observed during the following three months. Intravitreal triamcinolone injection may offer help in limiting the damage in this small group of patients with a relatively short history of visual loss due to NAION.
AuthorsAylin Yaman, Ozlem Barut Selver, A Osman Saatci, Meltem F Soylev
JournalClinical & experimental optometry (Clin Exp Optom) Vol. 91 Issue 6 Pg. 561-4 (Nov 2008) ISSN: 0816-4622 [Print] United States
PMID18976422 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Glucocorticoids
  • Triamcinolone Acetonide
Topics
  • Acute Disease
  • Adult
  • Aged
  • Arteritis (drug therapy)
  • Female
  • Glucocorticoids (therapeutic use)
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Optic Neuropathy, Ischemic (drug therapy)
  • Triamcinolone Acetonide (therapeutic use)
  • Visual Acuity (drug effects)
  • Visual Fields (drug effects)
  • Vitreous Body

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: